Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CODEX DNA, INC.

(DNAY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Codex DNA : Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officer; Compensatory Arrangement of Certain Officers (Form 8-K)

09/16/2021 | 05:12pm EST
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officer; Compensatory Arrangement of Certain Officers.

Departure of Named Executive Officer

Codex DNA, Inc. (the 'Company') and Timothy E. Cloutier have entered into an agreement (the 'Separation Agreement') pursuant to which Mr. Cloutier will depart the Company on September 17, 2021. Under the Separation Agreement, Mr. Cloutier will be entitled to various severance benefits (the 'Severance Benefits') previously approved by the Company's Board of Directors for employees at the Senior Vice President level in the Company. Mr. Cloutier's receipt of the Severance Benefits was subject to his execution of the Separation Agreement, which contains, among other provisions, a general release and waiver of claims. Mr. Cloutier's departure was not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.

The foregoing description of the Separation Agreement does not purport to be complete and is qualified in its entirety by reference to the complete text of the Separation Agreement. A copy of the Separation Agreement will be filed as an exhibit to the Company's quarterly report on Form 10-Q for the fiscal quarter ending September 30, 2021.



Disclaimer

Codex DNA Inc. published this content on 16 September 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 16 September 2021 21:11:03 UTC.


ę Publicnow 2021
All news about CODEX DNA, INC.
11/29Codex DNA Announces Commercial Availability of Automated mRNA Synthesis Kit with Integr..
AQ
11/29Codex DNA, Inc. Announces Commercial Availability of Automated mRNA Synthesis Kit with ..
CI
11/22CODEX DNA, INC. : Other Events (form 8-K)
AQ
11/18Codex DNA, Inc. completed the acquisition of Eton Bioscience, Inc.
CI
11/11Codex DNA to Present at the Jefferies London Healthcare Conference
AQ
11/10CODEX DNA, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exh..
AQ
11/10Codex DNA, Inc. Enters into A Second Amendment to Loan and Security Agreement with Sili..
CI
11/09CODEX DNA : Q3 Earnings Snapshot
AQ
11/09Codex DNA Acquires Eton Bioscience - Form 8-K
PU
11/09Earnings Flash (DNAY) CODEX DNA Posts Q3 Revenue $2.79M, vs. Street Est of $2.93M
MT
More news
Analyst Recommendations on CODEX DNA, INC.
More recommendations
Financials (USD)
Sales 2021 11,8 M - -
Net income 2021 -37,3 M - -
Net Debt 2021 - - -
P/E ratio 2021 -4,64x
Yield 2021 -
Capitalization 188 M 188 M -
Capi. / Sales 2021 16,0x
Capi. / Sales 2022 7,44x
Nbr of Employees 133
Free-Float 47,3%
Chart CODEX DNA, INC.
Duration : Period :
Codex DNA, Inc. Technical Analysis Chart | DNAY | US1920031010 | MarketScreener
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 6,41 $
Average target price 25,00 $
Spread / Average Target 290%
EPS Revisions
Managers and Directors
Todd R. Nelson President, Chief Executive Officer & Director
Jennifer Isacoff McNealey Chief Financial Officer
Daniel G. Gibson Chief Technology Officer
Justin O. Emory Vice President-Information Technology
Franklin R. Witney Independent Director
Sector and Competitors
1st jan.Capi. (M$)
CODEX DNA, INC.0.00%188
THERMO FISHER SCIENTIFIC33.59%245 196
DANAHER CORPORATION38.16%219 304
INTUITIVE SURGICAL, INC.17.94%115 663
SIEMENS HEALTHINEERS AG51.93%80 663
EDWARDS LIFESCIENCES CORPORATION20.38%69 900